Description: Aricept, Exelon and Reminyl are now approved for listing on the Pharmaceutical Benefits Schedule (PBS) but only for people with mild to moderate Alzheimer’s disease and subject to certain conditions. This Update Sheet provides information about the conditions that need to be met in order to receive these medications at the subsidised rate.
These help sheets are in an Adobe Portable Document Format. They require Adobe Reader to be viewed. You can download and install Acrobat Reader® for free from the Abode homepage by clicking on the image below.
However should you have problems downloading the PDF version of any help sheet, or require a hardcopy of the same, please contact us on (08) 9388 2800.
